bathophenanthroline has been researched along with osmium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dvořák, Z; Štarha, P; Trávníček, Z; Vančo, J | 1 |
| Brabec, V; Kasparkova, J; Kostrhunova, H; Novohradsky, V; Pracharova, J; Štarha, P; Trávníček, Z | 1 |
| Brabec, V; Kasparkova, J; Kostrhunova, H; Markova, L; Novohradsky, V; Trávníček, Z | 1 |
3 other study(ies) available for bathophenanthroline and osmium
| Article | Year |
|---|---|
Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand.
Topics: Cell Proliferation; Coordination Complexes; Dichloroacetic Acid; Drug Liberation; Female; Humans; Ligands; Osmium; Ovarian Neoplasms; Phenanthrolines; Ruthenium | 2018 |
Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Osmium; Phenanthrolines; Ruthenium; Triple Negative Breast Neoplasms | 2018 |
An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chloroacetates; Coordination Complexes; Cymenes; Female; Humans; Necroptosis; Necrosis; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Organoplatinum Compounds; Osmium; Phenanthrolines; Tumor Microenvironment | 2019 |